期刊文献+

大鼠骨髓间充质干细胞体外诱导失巢凋亡过程中半胱氨酸蛋白酶-3的作用 被引量:2

Significance of casepase-3 in induced anoikis of mesenchymal stem cells(MSCs)in vitro
下载PDF
导出
摘要 [目的]探讨在体外诱导骨髓间充质干细胞失巢凋亡过程中半胱氨酸蛋白酶-3(Caspase-3)的作用。[方法]将体外培养的骨髓间充质干细胞随机分为3组:对照组、诱导凋亡组、抑制凋亡组。应用Caspase-3活性检测试剂盒,荧光比色法和W estern b lotting法检测失巢凋亡中Caspase-3活性的改变;借助流式细胞仪分析骨髓间充质干细胞凋亡的变化。[结果]流式细胞术显示诱导凋亡组出现了明显的凋亡峰,凋亡率随诱导时间的延长而明显增加;其它两组的凋亡率较低且较稳定。W estern b lotting检测和Caspase-3活性荧光检测显示,诱导凋亡组Caspase-3的活性以及蛋白表达水平随诱导凋亡时间的延长而明显升高,且与细胞凋亡率相关,以后者更灵敏,其余两组活性无明显变化。[结论]Caspase-3蛋白在诱导骨髓间充质干细胞失巢凋亡的过程中发挥着重要作用;抑制Caspase-3的活性可以有效降低细胞失巢凋亡率。 [ Objective] To investigate the significance of Caspase-3 in anoikis induced by preventing mesenchymal stem cells (MSCs) from adherence in vitro. [ Method ] The cultured MSCs were randomly divided into 3 groups: control group, induced group and Caspase-3 inhibitor group. MSCs anoikis was detected by flow cytometry. The caspase-3 activity was evaluated by Caspase-3 Fluorometric Assay Kit and Western blotting. [ Result ] The flow cytometry analysis showd that apoptosis peak was appeared significantly in the induced groupand increased dramaticly along with the apoptosis conditions going on. The apoptosis rate of the others were lower and stable. Western blotting and fluorometric assay showed the caspase-3 expressive level or activity in induced group was the highest and was related with its apoptosis rate. The fluorometric assay technique was sensitive to the western blotting. [ Conclusion ] Caspase-3 plays a vital role in suspended culture induced anoikis of MSCs in vitro. Decreasing the activity of caspase-3 by Caspase-3 Inhibitor can reduce the anoikis rate.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2006年第11期849-851,866,共4页 Orthopedic Journal of China
基金 国家自然科学基金资助课题(No.30471753)
关键词 骨髓问充质干细胞 CASPASE-3 失巢凋亡 Mesenchymal stem cells Caspase-3 Anoikis
  • 相关文献

参考文献16

  • 1Frisch SM,Francis H.Disruption of epithelial cell-matrix interactions induces apoptosis[J].Cell Biol,1994,124:619-626.
  • 2Meredith JE,Jr,Schwartz MA.IntegrinsAdhesion,and apoptosis,Trends Cell Biol[J].1997,7:146-150.
  • 3Alnemri ES.Mammalian cell death proteases:a family of highly conserved aspartate specific cysteine proteases[J].Cell Biochem,1997,64:33-42.
  • 4Porter AG,Janicke RU.Emerging roles of Caspase-3 in apoptosis[J].Cell Death Differ,1999,6:99-104.
  • 5Graham Jones,Joel Machado,Jr,et al.PTEN-independent Induction of Caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain in Human Astrocytic Brain Tumors Which Highly Express Focal Adhesion Kinase[J].Cancer Reserch,2001,61:5688-5691.
  • 6Kojo S J,Elenitoba-Johnson,Stephen D,et al.Involvement of multiple signaling pathways in follicular lymphoma transformation:p38-mitogenactivated protein kinase as a target for therapy[J].Proc Natl Acad Sci USA,2003,(100) 12:7259-7264.
  • 7Frisch S M,Ruoslahti E.Integrins and anoikis[J].Curr Opin Cell Biol,1997,9:701-706.
  • 8Lukashev ME,Werb Z.ECM signalling:orchestrating cell behaviour and misbehaviour[J].Trends Cell Biol,1998,8:437-441.
  • 9Zhou CF,Ye F,CaD LH,et al.Overexpression of integrin a5p 1 in human hepatocellular carcinoma cell line suppresses cell proliferation in vitro and tumorigenicity in nude mice[J].Mol Cell Biochem,2000,207:49-55.
  • 10Giancotti FG,Ruoslahti E.lntegrin signaling[J].Science,1999,285(5430):1028-1032.

同被引文献35

  • 1王宗立,范红杰,庞超健,马玉朝.骨髓间充质干细胞移植对缺血再灌注大鼠脑神经细胞凋亡及survivin、caspase-3蛋白表达的影响[J].中国医科大学学报,2009,38(11):834-837. 被引量:5
  • 2李静,王文,王宗仁.芪丹通脉片联合骨髓间充质干细胞修复损伤内皮细胞Caspase-3、c-IPI-1和c-IPI-2的表达[J].中医药导报,2007,13(2):9-11. 被引量:4
  • 3Introna M, Lucchini G, Dander E, et al. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients [J]. Biol Blood Marrow Transplant, 2014, 20 ( 3 ) : 375-381.
  • 4Resnick I B, Barkats C, Shapira M Y, et al. Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC) [J]. Am J Blood Res, 2013, 3 ( 3 ) :225-238.
  • 5Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardio- poietic stem Cell therapy in heart failure) multicenter randomized trial with lineage-specified biologics [J]. J Am Coil Cardiol, 2013, 61 ( 23 ) : 2329-2338.
  • 6Forostyak S, Jendelova P, Sykova E. The role of mesenchy- mal stromal cells in spinal cord injury, regener-ative medicine and possible clinical applications [J]. Biochimie, 2013, 95 ( 12 ) : 2257-2270.
  • 7Karamouzian S, Nematollahi-Mahani S N, Nakhaee N, et al. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients [J]. Clin Neurol Neurosurg, 2012, 114 ( 7 ) : 935-939.
  • 8Amer M E, E1-Sayed S Z, E1-Kheir W A, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte- like cells [J]. Eur J Gastroenterol Hepatol, 2011, 23 ( 10 ): 936-941.
  • 9Skrahin A, Ahmed R K, Ferrara G, et al. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial [J]. Lancet Respir Med, 2014, 2 ( 2 ) : 108-122.
  • 10Wilson J G, Liu K D, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial [J]. Lancet Respir Med, 2015, 3 ( 1 ) : 24-32.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部